DalsnaFinance › Analyst accuracy › Piper Sandler › STAA target
Stifel upgrades STAAR Surgical stock rating on China growth outlook
Piper Sandler reiterated a Neutral rating with a price target of $33.
A fact about what Piper Sandler published, as reported by Investing.com, not a recommendation from Dalsna Finance; Piper Sandler is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.